Blood Safety Management System in Foreign Countries.
- Author:
Donghan LEE
1
;
Jina OH
;
Jeeyeon SHIN
;
Jeongran KWON
;
Kyoungyul LEE
;
Minsun SONG
;
Youngsill CHOI
Author Information
1. The Division of Human Blood Safety Surveillance, Korea Centers for Disease Control and Prevention, Cheongwon, Korea. ldhmd@korea.kr
- Publication Type:Review
- Keywords:
Blood safety;
Hemovigilance;
Human T-lymphotropic virus (HTLV)
- MeSH:
Austria;
Blood Safety*;
Centers for Disease Control and Prevention (U.S.);
Creutzfeldt-Jakob Syndrome;
Germany;
Humans;
Japan;
Korea;
National Health Programs;
Red Cross;
Tissue Donors;
Viruses
- From:Korean Journal of Blood Transfusion
2013;24(3):217-221
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
In an effort to improve the blood safety management system, Korea Centers for Disease Control and Prevention visited the national agencies and blood centers of foreign countries. In Japan, the management system for Human T-lymphotropic virus positive donors is operated. In Germany, Red Cross Blood Centers provide 75~80% of national blood consumption, and hospital blood centers provided 15~20%. In addition, the Paul Ehrlich Institut is engaged in blood center management and blood product safety, and the Robert Koch Institut manages transfusion-transmitted infection. The standard temperature of RBC transport is 1~10degrees C. In Austria, haemovigilance is operated by the National Blood Authority and adverse reactions following transfusion are investigated by Blood Centers. In Britain, blood is provided by National Health Service Blood and Transplant, and the Serious Hazards of Transfusion, haemovigilance system is operated. Universal leukoreduction has been performed since 1999 in order to prevent transmission of variant Creutzfeldt-Jakob disease.
